Ascletis Pharma Inc 2025 Annual Report with Sustainability Disclosures
Company: Ascletis Pharma Inc
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 205
The report describes Asclepis Pharma Inc.'s 2025 ESG performance across directly controlled businesses and a Board-led ESG Committee structure. It reports Scope 1 and Scope 2 emissions of 2,749.78 tonnes carbon dioxide equivalent, total energy consumption of 5,931.41 megawatt-hour and water consumption of 16,277.77 cubic metre. The Group had 202 employees, reported zero work-related fatalities and no corruption, bribery, fraud or money-laundering cases. Its 2021-based GHG emission-intensity target concluded in 2025 without being achieved.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.